ESRG
Embryonic stem cell-related gene protein
Also known as: ESRG_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for ESRG in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
222 residues, UniProt reviewed canonical sequence.
>Q1W209|ESRG
1 MTLFSDSARL HPGEINSLVA HTKPVWWSLH TDAHEIWCRD SDRGTSLGRS IPCPPALCSV
61 RKIHLRPQVL RPTSPRNISP ISNPVSGLFL LCSPTSLTIP QPLSPFNLGA TLQSLPSLNF
121 NSFHSLVETK ETCFIREPKT PAPVTDWEGS LPLVFNHCRD ASLISRFRPR RDACLGPSPL
181 AASPAFLGQG QVPLNPFSFT LSGKSRFSGA GASTPQPLLL HPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ESRG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.73
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ESRG as an antibody target. Whether an autoantibody or antibody against ESRG could matter depends on whether native ESRG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ESRG is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ESRG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...